Cardiomyocyte apoptosis in animal models of obesity

Area of Science:

• Cardiology
• Molecular Biology
• Pathophysiology

Background:

• Cardiovascular disease (CVD) mortality rose dramatically in the 20th century, coinciding with increased obesity prevalence.
• Obesity is a major risk factor for CVD, yet the underlying mechanisms are not fully understood.
• Cardiomyocyte apoptosis (programmed cell death) is implicated in obesity-associated heart dysfunction.

Purpose of the Study:

• To critically review animal model studies on obesity-induced cardiomyocyte apoptosis.
• To elucidate the mechanisms linking obesity to heart disease through myocyte cell death.
• To understand the role of apoptosis in various obesity-related cardiovascular conditions.

Main Methods:

• Review of existing literature on animal models of obesity.
• Analysis of studies investigating cardiomyocyte apoptosis mechanisms.
• Synthesis of findings on the role of apoptosis in obesity-associated CVD.

Main Results:

• Obesity significantly elevates the rate of cardiomyocyte apoptosis.
• Specific molecular pathways mediating obesity-induced apoptosis have been identified in animal models.
• Increased myocyte apoptosis contributes to cardiac dysfunction and disease progression in obesity.

Conclusions:

• Cardiomyocyte apoptosis is a critical mechanism in the development of obesity-associated heart disease.
• Understanding these apoptotic pathways in animal models provides insights into human CVD.
• Targeting apoptosis may offer therapeutic strategies for obesity-related cardiovascular complications.